Advertisement

Topics

Novo Nordisk's Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients http://bit.ly/2IT3W1s  @novonordisk #diabetes #type1diabetes

14:15 EDT 12 Oct 2018 | Pharmafile

Novo Nordisk's Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients http://bit.ly/2IT3W1s 

Original Article: Novo Nordisk's Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients http://bit.ly/2IT3W1s  @novonordisk #diabetes #type1diabetes

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk's Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients http://bit.ly/2IT3W1s  @novonordisk #diabetes #type1diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...